We first performed a qRT-PCR analysis of the FOXM1 expression in 13 malignant melanoma cell lines, NHEMs and a human pancreatic cancer cell line, PANC1, as a positive control. This evidence concerns the gene FOXM1 and familial pancreatic carcinoma.